Completed NA INTERVENTIONAL 2-arm NCT04791475

Comparison Of Dexmedetomidine And Dexamethasone As An Adjuvant To Bupivacaine In Brachial Plexus Block

Comparison Of Dexmedetomidine And Dexamethasone As An Adjuvant To Bupivacaine In Ultrasound Guided Supraclavicular Brachial Plexus Block In Upper Limb Surgeries

Sponsor: Tribhuvan University Teaching Hospital, Institute Of Medicine.

Conditions Brachial Plexus Block Bupivacaine Dexamethasone Dexmedetomidine

Interventions adding Dexmedetomidine and dexamethasone to bupivacaine in USG guided supraclavicular brachial plexus block.

Updated 5 times since 2021 Last updated: Jul 16, 2022 Started: Feb 22, 2021 Primary completion: Jan 1, 2022 Completion: Jan 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Brachial Plexus Block and Bupivacaine, this trial is completed. The trial is conducted by Tribhuvan University Teaching Hospital, Institute Of Medicine. and has accumulated 5 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2022 — Jul 2024 [monthly]

Completed NA
Jul 2022 — Sep 2022 [monthly]

Completed NA

Status: Recruiting → Completed
Apr 2021 — Jul 2022 [monthly]

Recruiting NA

First recorded

Feb 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tribhuvan University Teaching Hospital, Institute Of Medicine.

Data source: Tribhuvan University Teaching Hospital, Institute Of Medicine.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kathmandu, Nepal